We have observed a strong trend toward more NRF2 highly stained tumors within the TP53/CNH-like group, known to be of poor prognosis [ 2 ], consistent with previous reports describing higher NRF2 expression with advanced stage and high tumor grade in endometrial carcinomas [ 32 ].
← all excerpts
The NRF2 transcriptional target NQO1 has low mRNA levels in TP53-mutated endometrial carcinomas.
1
—
—